Connect to our triple helix ecosystem.
It’s our DNA for your success
Experience shows life sciences thrive where there is a supportive and collaborative ecosystem that fosters a climate of innovation set within a commercial framework. The Medicon Valley ecosystem provides just that through a unique three-strand approach that we call our triple helix. It is our DNA, our recipe for your success whether you are an international investor or a company looking to locate to Medicon Valley.
The triple combination of government agencies, research infrastructure and business networks create a holistic approach to life science development in Medicon Valley. Working in an intensive, integrated and connected way they help academia and business to cooperate, share ideas, innovate, and secure business success. The result is a sophisticated ecosystem focused on driving up opportunities and driving down time-to-market.
Medicon Valleys ecosystem in short
Strategic approach to life science development
Medicon Valley is a strategically important life science development area for both Swedish and Danish government agencies. Ambitious strategies are focused on building the cluster by facilitating research and innovation, which have already resulted in several successful partnerships and business successes. An important part of the strategic approach is to make it very easy for international investors and companies to set-up, which increases the value for the cluster and the incoming investor.
Advanced research support and facilities create a bright future
Medicon Valley has all the right research support already in place for you. Our Technology Transfer Organisations (TTO) provide the right assistance at the right time to innovators, while incubators and science parks provide fertile environments that stimulate innovation, collaboration and growth. Clinical trials and research at hospitals are co-ordinated through a highly efficient one-point-entry model that speeds up requests and secures the right quality. Test facilities for medical devices and new eHealth solutions are also well catered for.
Visualisation of the MAX IV Laboratory outside Lund, Sweden
Medicon Valley is set to become one of Europe’s most exciting life science innovation clusters. Powerful research facilities for innovative research into materials science and life science are underway. The European Spallation Source is due to open in 2019, and the laser synchrotron source MAX IV, will open in 2016. In advanced medical research, the Steno Diabetes Center opens in 2020 and new support organisations such as Innovation Skåne are focusing on exciting new mHealth solutions.
Building bridges between business and academia
Strengthening the collaboration and exchange of knowledge between academia and companies plays a vital role in focusing research and innovation towards real business opportunities. Medicon Valley Alliance (MVA) is one of our organizations dedicated to this aim. MVA promotes initiatives and network events on behalf of the life science community to open up new research and business opportunities.